ArticleGenes & cancer2017

Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines.

Ombretta Melaiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.